BIOQUAL, Inc.
BIOQ
$43.19
-$0.25-0.58%
OTC PK
| 02/28/2025 | 11/30/2024 | 02/29/2024 | 11/30/2023 | 05/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 177.21% | -79.51% | -43.26% | -46.11% | 38.40% |
| Total Depreciation and Amortization | 262.16% | -123.24% | 350.86% | -116.61% | 578.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -81.52% | -- | -48.95% | -- | -162.72% |
| Change in Net Operating Assets | 53.16% | -79.74% | -99.97% | 171.12% | 321.01% |
| Cash from Operations | 112.94% | -53.64% | -57.35% | 664.66% | 52.02% |
| Capital Expenditure | -0.74% | 92.80% | 4.91% | -142.88% | -24,381.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -0.74% | 92.80% | 4.91% | -142.88% | -24,318.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | -- | 100.00% | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | -- | 100.00% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.09% | -64.69% | -54.73% | 541.74% | 19.94% |